By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Pitcairn House
First Avenue
Burton-on-Trent  Staffordshire  DE14 2WW   United Kingdom
Phone: 44-0-1283-494-340 Fax: n/a



Company News
Clinigen Year End Trading Update 7/20/2016 9:45:35 AM
Clinigen And Galen Enter Exclusive Global Access Agreement For Chemotherapy Drug Daunoxome 6/14/2016 9:45:54 AM
Clinigen Announces Partnership With Basilea (BSLN.SW) To Initiate A Managed Access Program For Isavuconazole To Treat Patients With Invasive Fungal Infections In Europe 6/9/2016 12:46:27 PM
Clinigen Expands U.S. Presence With Opening Of New Yardley Headquarters 5/19/2016 10:45:32 AM
Clinigen Joins Two Key European Alliances In The Fight To Protect Patients From The Threat Of Counterfeit Drugs 3/30/2016 8:47:16 AM
Clinigen Acquires U.S.-Approved Totect (Dexrazoxane) From Biocodex To Become The Only Global Source For The Treatment Of Anthracycline Extravasation 3/2/2016 9:18:49 AM
Clinigen Continued Strong Growth With EPS Up 21% 3/2/2016 9:15:58 AM
On Rare Disease Day, Clinigen And CheckOrphan Celebrate Over 100 Rare Disease Access Programs Added To Online Register 2/29/2016 9:51:36 AM
Clinigen Release: Half Year Trading Update 1/19/2016 1:43:36 PM
Sunesis (SNSS) Partners With Clinigen To Initiate A Compassionate Use Program For Patients With Relapsed Or Refractory Acute Myeloid Leukemia 12/3/2015 7:46:47 AM